TIMP3 rs121918351: What Your Genotype Means
The rs121918351 variant is a rare genetic change in the TIMP3 gene that alters the protein's structure. It is a known pathogenic driver of Sorsby fundus dystrophy, an inherited condition that can lead to vision loss.
What each genotype means
Typical TIMP3 genotype
This genotype represents the common, non-mutated sequence for this location in the TIMP3 gene. It is not associated with the development of Sorsby fundus dystrophy.
This is the most common genotype found in the general population.
Sorsby fundus dystrophy risk
This genotype contains the Ser181Cys mutation, which is a known pathogenic driver of Sorsby fundus dystrophy. This condition is inherited in an autosomal dominant manner and is associated with premature macular choroidal neovascularization and potential vision loss. Please consult with an ophthalmologist or a genetic counselor to discuss clinical implications and monitoring.
This genotype is extremely rare in the general population, with a frequency of less than 0.00005 in gnomAD.
Sorsby fundus dystrophy risk
This genotype indicates the presence of the Ser181Cys mutation on both copies of the TIMP3 gene. Because this condition is typically inherited in an autosomal dominant pattern, this genotype is associated with a high risk for Sorsby fundus dystrophy and related retinal degeneration. Please consult with an ophthalmologist or a genetic counselor to discuss clinical implications and monitoring.
This genotype is exceptionally rare and is not typically observed in the general population.
Understanding the rs121918351 Variant
The variant rs121918351 is a specific genetic alteration located within the TIMP3 gene. In genetic terms, this variant represents a change where the amino acid serine is replaced by cysteine at position 181 of the protein, often referred to as Ser181Cys. This gene is situated on chromosome 22. Because this variant is located in a critical region of the gene, it can significantly impact the function of the resulting protein. Genetic variants like this are identified by their unique reference SNP cluster ID (rsID), which acts as a standardized label for researchers and clinicians to track specific positions in the human genome. While many variants in our DNA have no observable effect, those that alter protein structure, such as rs121918351, are studied closely for their potential to influence health outcomes.
The Role of the TIMP3 Gene
The TIMP3 gene provides instructions for making a protein called tissue inhibitor of metalloproteinases-3. This protein plays a vital role in maintaining the health of the extracellular matrix, which is the structural framework that supports cells in various tissues, including the eye. TIMP3 acts as a regulator, controlling the activity of enzymes that break down this matrix. When the TIMP3 protein is functioning correctly, it helps ensure that the balance between building and breaking down tissue is maintained. In the context of the retina, this regulation is essential for preventing abnormal blood vessel growth. Mutations in this gene can disrupt this delicate balance, leading to the accumulation of abnormal proteins or the failure to properly inhibit enzymes, which can ultimately compromise the integrity of the retinal tissue and lead to degenerative changes.
Research and Clinical Associations
Scientific research has established a strong link between mutations in the TIMP3 gene, including rs121918351, and Sorsby fundus dystrophy. This is a rare, autosomal dominant condition characterized by the progressive degeneration of the macula, the part of the eye responsible for sharp, central vision. The primary clinical concern associated with this variant is the development of choroidal neovascularization, where abnormal blood vessels grow beneath the retina, often leading to vision loss in adulthood. The evidence for this association is considered robust within the context of familial studies, where the condition is passed down through generations. Because the inheritance pattern is autosomal dominant, an individual only needs to inherit one copy of the altered gene from an affected parent to be at risk for the condition. Research continues to explore how these specific protein changes trigger the disease process.
Population Frequency and Prevalence
The rs121918351 variant is extremely rare in the general population. According to large-scale genomic databases like gnomAD, the frequency of this specific variant is well below 0.00005. Because it is so uncommon, it is not typically found in the general screening of the population. Instead, its presence is usually identified through targeted genetic testing in families that have a known history of Sorsby fundus dystrophy. The rarity of the variant underscores that it is not a common cause of macular degeneration in the general public. Its clinical significance is almost entirely confined to specific familial clusters where the mutation has been inherited. If you have concerns about your family history or potential genetic risks, it is important to consult with a genetic counselor or an ophthalmologist who specializes in inherited retinal diseases.
Navigating Genetic Information
It is important to understand that genetic information is complex and should always be interpreted by a qualified healthcare professional. If you or a family member have been identified as carrying the rs121918351 variant, this does not constitute a medical diagnosis on its own, but it does warrant a discussion with a specialist. A clinician can provide context based on your personal and family health history, explain the implications of the variant, and discuss appropriate monitoring or management strategies. You cannot use this information to self-diagnose or predict the exact timing of symptoms, as the expression of genetic conditions can vary even among family members. Always rely on clinical evaluations, such as eye exams and imaging, to assess your ocular health. Never make changes to your medical care or health management based solely on a genetic report without consulting your doctor.
How common is this variant?
The rs121918351 variant is extremely rare in gnomAD, with a frequency of less than 0.00005, and is primarily observed in familial clusters.
Frequently asked questions
What is Sorsby fundus dystrophy?
Sorsby fundus dystrophy is a rare, inherited eye disorder that causes progressive damage to the macula. It often leads to vision loss in early to mid-adulthood due to the growth of abnormal blood vessels in the eye.
Is rs121918351 the same as Ser181Cys?
Yes, rs121918351 is the identifier for the genetic variant that results in the Ser181Cys protein change. The rsID refers to the DNA location, while Ser181Cys describes the resulting change in the protein's amino acid sequence.
How is this variant inherited?
This variant follows an autosomal dominant inheritance pattern. This means that an individual only needs to inherit one copy of the variant from one parent to be at risk for the associated condition.
Should I get tested for this variant?
Genetic testing for this specific variant is generally only recommended if there is a known family history of Sorsby fundus dystrophy. You should discuss the necessity and implications of such testing with a genetic counselor or your eye doctor.
Sources & further reading
Educational information only, last refreshed 10/13/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs121918351?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in TIMP3
Pathogenic missense substitution (p.Ser181Cys) in TIMP3 causing Sorsby fundus dystrophy, leading to choroidal neovascularization and macular degeneration.
Pathogenic missense variant (p.Ser181Cys) in TIMP3 causing classic Sorsby fundus dystrophy characterized by choroidal neovascularization and macular degeneration.
Variant in the TIMP3 signal sequence region associated with abnormal cleavage and atypical macular dystrophy.